Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer

Affiliations

¹ Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada.

Editorial

Khaled Ajib et al. Transl Androl Urol. 2018 Dec.

. 2018 Dec;7(Suppl 6):S723-S726.

doi: 10.21037/tau.2018.10.01.

¹ Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
Audenet F, Waingankar N, Ferket BS, Niglio SA, Marqueen KE, Sfakianos JP, Galsky MD. Audenet F, et al. J Urol. 2018 Nov;200(5):996-1004. doi: 10.1016/j.juro.2018.06.001. Epub 2018 Jun 4. J Urol. 2018. PMID: 29879397

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. 10.1002/ijc.29210 - DOI - PubMed
1. American Cancer Society. Cancer Facts & Figures 2017. Atlanta, GA: American Cancer Society; 2017.
1. Prout GR, Marshall VF. The prognosis with untreated bladder tumors. Cancer 1956;9:551-8. 10.1002/1097-0142(195605/06)9:3<551::AID-CNCR2820090319>3.0.CO;2-2 - DOI - PubMed
1. Arcangeli G, Strigari L, Arcangeli S. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials. Crit Rev Oncol Hematol 2015;95:387-96. 10.1016/j.critrevonc.2015.04.006 - DOI - PubMed
1. Cookson MS. The surgical management of muscle invasive bladder cancer: a contemporary review. Semin Radiat Oncol 2005;15:10-8. 10.1016/j.semradonc.2004.07.009 - DOI - PubMed